R. Deconti

发表

Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin

M. Jaroszeski, D. Reintgen, R. Heller, 1998, Cancer.

Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).

R. Lange, R. Deconti, B. Toftness, 1973, Cancer research.

Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial

P. Munster, D. Sullivan, A. Daud, 2009, Clinical Cancer Research.

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck

D. Neuberg, G. Adams, A. Forastiere, 1998, Cancer.

Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma.

T. Padhya, D. Boulware, A. Trotti, 2009, Archives of otolaryngology--head & neck surgery.

Immunosuppression by 5‐fluorouracil

R. Deconti, M. Mitchell, 1970, Cancer.

Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.

M. Atkins, F. Haluska, M. Ernstoff, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin‐D, and cyclophosphamide for advanced sarcoma

D. Schoenfeld, J. Wolter, J. Horton, 1982, Cancer.

A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck

A. Argiris, B. Burtness, R. Axelrod, 2011, Cancer.

Potential for Immunotherapy in Merkel Cell Carcinoma

V. Sondak, R. Deconti, K. McLean, 2010 .

Changes in Dendritic Cell Phenotype After a New High-dose Weekly Schedule of Interleukin-2 Therapy for Kidney Cancer and Melanoma

M. Fishman, Daohai Yu, A. Daud, 2010, Journal of immunotherapy.

Long‐term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy

J. Bertino, R. Deconti, J. Cornog, 1975, Cancer.

Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma

V. Sondak, T. Padhya, M. Schell, 2015, Cancer.

A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer

D. Schoenfeld, R. Deconti, 1981, Cancer.

Development of a combination chemotherapy program for adult acute leukemia: CAM and CAM‐L

J. Bertino, R. Deconti, J. Marsh, 1973, Cancer.

RESPONSE OF PSORIASIS TO N-PHOSPHONACETYL-L-ASPARTATE

J. Rubin, R. Deconti, R. Earhart, 1981, The Lancet.

Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393.

B. Murphy, E. Rowinsky, G. Adams, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma.

D. Reintgen, J. Messina, F. Glass, 1997, The Journal of the Florida Medical Association.

The Florida Melanoma Trial I: A Prospective Multi-center Phase I/II Trial of Post-operative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-alpha in the Treatment of Advanced Stage III Melanoma

V. Sondak, C. Gwede, D. Reintgen, 2008 .

Systemic treatments for merkel cell carcinoma.

R. Kudchadkar, R. Deconti, 2010, Current problems in cancer.

Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.

K. Rowland, S. Taylor, R. Deconti, 1986, Cancer treatment reports.

Chemotherapy of cancer of the head and neck

J. Bertino, R. Deconti, M. Mosher, 1973, Cancer.

A Phase II Trial of Imatinib Mesylate in Merkel Cell Carcinoma (Neuroendocrine Carcinoma of the Skin): A Southwest Oncology Group Study (S0331)

V. Sondak, M. Heinrich, J. Moon, 2010, American journal of clinical oncology.

Clinical and biochemical studies of high-dose intermittent therapy of solid tumors with hydroxyurea (NSC-32065).

R. Deconti, W. Creasey, R. Capizzi, 1970, Cancer chemotherapy reports.

Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer.

S. Remick, J. Horton, J. Ruckdeschel, 1996, American journal of clinical oncology.

A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer

G. Lyman, H. Lazarus, J. Ruckdeschel, 1991, Cancer.

Amenorrhea in patients with Hodgkin's disease treated with antineoplastic agents.

R. Levine, R. Levine, L. Sobrinho, 1971, American journal of obstetrics and gynecology.

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

Richard Heller, V. Sondak, P. Munster, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease.

R. Deconti, P. Calabresi, 1966, The New England journal of medicine.

Time-Specified Delivery of Chemotherapy by Implantable Programmable Pumps — Preliminary Data on 5-Fluoro-2’-deoxyuridine

W. Hrushesky, R. Deconti, L. Scheving, 1991 .

Detection of Submicroscopic Lymph Node Metastases with Polymerase Chain Reaction in Patients with Malignant Melanoma

D. Reintgen, L. Moscinski, F. Glass, 1994, Annals of surgery.

Biochemical studies with 1 beta-D-arabinofuranosylcytosine in human leukemic leukocytes and normal bone marrow cells.

S. Kaplan, R. Deconti, W. Creasey, 1968, Cancer research.

Molecular Staging of Malignant Melanoma

G. Lyman, D. Reintgen, J. Messina, 2013 .

Molecular staging of malignant melanoma: correlation with clinical outcome.

G. Lyman, D. Reintgen, J. Messina, 1998, JAMA.

Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone.

J. Bertino, A. Sartorelli, R. Deconti, 1972, Cancer research.

Hypersensitivity vasculitis associated with 2-deoxycoformycin and allopurinol therapy.

R. Deconti, R. Ginsburg, J. Steinmetz, 1989, The American journal of medicine.

Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy.

D. Miklavcic, S. Orlowski, L. Mir, 1998, British Journal of Cancer.

Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma.

C W Cruse, M. Ross, G. Lyman, 1996, Annals of surgery.

Chemotherapy of squamous cell carcinoma of the skin.

R. Deconti, 2012, Seminars in oncology.

Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma).

D. Reintgen, J. Messina, F. Glass, 2000, Cancer control : journal of the Moffitt Cancer Center.

Management of Recurrent and Metastatic Merkel Cell Carcinoma

R. Deconti, 2010 .

Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma.

W. Samlowski, R. Deconti, S. Donepudi, 2012, Seminars in oncology.

Adjuvant Chemotherapy of Merkel Cell Carcinoma

R. Deconti, 2010 .

Postoperative concurrent chemotherapy and radiotherapy for high‐risk cutaneous squamous cell carcinoma of the head and neck

T. Padhya, A. Trotti, J. Kish, 2015, Head & neck.

Squamous cell carcinoma with rhabdoid phenotype of skin/soft tissue in a transplant patient: An exceptional case and review of the literature

M. Bui, S. Altiok, R. Deconti, 2013, Diagnostic cytopathology.

Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma.

M. Ernstoff, A. Bedikian, R. Deconti, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy

M J Jaroszeski, L. Mir, M. Jaroszeski, 1996, Cancer.

Biochemical Studies with l-/8-D-Arabinofuranosylcytosine in Human Leukemic Leukocytes and Normal Bone Marrow Cells1

William, S. Kaplan, R. Deconti, 2006 .

Immunosuppressive effects of cytosine arabinoside and methotrexate in man.

M. Wade, J. Bertino, R. Deconti, 1969, Annals of internal medicine.

Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.

H. Pehamberger, M. Gore, J. Kirkwood, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Calabresi P: Treatment of polycythemia vera with azauridine and azaribine.

R. Deconti, 1970, Annals of internal medicine.

Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.

J. Bertino, S. Kaplan, R. Deconti, 1968, Cancer research.

Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".

J. Bertino, R. Deconti, J. Marsh, 1970, Cancer research.

Abortifacient and teratogenic effects of triacetyl-6-azauridine in the monkey.

M. Wade, R. Deconti, R. Handschumacher, 1970, American journal of obstetrics and gynecology.

Improved therapeutic index of methotrexate with "leucovorin rescue".

J. Bertino, R. Deconti, E. Thomas, 1973, Cancer research.

Procarbazine in the management of late Hodgkin's disease.

R. Deconti, 1971, JAMA.

A phase II trial of PS-341 (bortezomib) followed by the addition of doxorubicin at progression in incurable adenoid cystic carcinoma of the head and neck: An Eastern Cooperative Oncology Group study.

C. Van Waes, A. Argiris, M. Goldwasser, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensity‐modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma

T. Padhya, J. Caudell, A. Trotti, 2013, Head & neck.

Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor.

V. Sondak, A. Daud, D. Gabrilovich, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II evaluation of Taxol in advanced head and neck cancer: an Eastern Cooperative Oncology group trial.

D. Neuberg, S. Taylor, G. Adams, 1993, Journal of the National Cancer Institute. Monographs.

Bleomycin therapy in advanced Hodgkin's disease and epidermoid cancers

J. Bertino, R. Deconti, M. Mosher, 1972, Cancer.

Phase II Trial of Karenitecin in Patients with Malignant Melanoma: Clinical and Translational Study

P. Munster, A. Daud, F. Hausheer, 2005, Clinical Cancer Research.

Survival following moderate‐dose preoperative radiation therapy for carcinoma of the rectum

J. Garb, R. Deconti, P. Friedmann, 1985, Cancer.

The tumor biology of melanoma nodal metastases.

G. Lyman, D. Reintgen, J. Messina, 1996, The American surgeon.

Paralytic brachial neuritis in Hodgkin's disease

R. Deconti, H. Bruckner, J. Pezzimenti, 1973, Cancer.

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.

B. Murphy, J. Ensley, M. Hussain, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma

V. Sondak, A. Daud, A. Yver, 2010, Cancer Chemotherapy and Pharmacology.

Survival after surgical resection of isolated pulmonary metastases from malignant melanoma.

A. Cantor, R. Deconti, L. Robinson, 2006, Cancer control : journal of the Moffitt Cancer Center.

Multiple primary melanomas: Implications for screening and follow-up programs for melanoma

D. Reintgen, A. Cantor, J. Messina, 2006, Annals of Surgical Oncology.

Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma

V. Sondak, A. Daud, J. Weber, 2010, British Journal of Cancer.

BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy

V. Sondak, R. Gonzalez, G. Gibney, 2016, Melanoma research.

Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes

D. Reintgen, J. Messina, E. Joseph, 1998, Annals of Surgical Oncology.

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

Jeffrey E. Lee, R. Elashoff, D. Morton, 2017, Annals of Surgical Oncology.

Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma

C. Horak, M. Schell, G. Gibney, 2014, Clinical Cancer Research.

The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up

V. Sondak, Daohai Yu, C. Gwede, 2012 .

Long-term survival results of a randomized multinational phase 3 trial of dacarbazine (DTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients (pts) with advanced malignant melanoma (MM)

H. Pehamberger, M. Gore, J. Kirkwood, 2005 .

Prognostic factors for survival after salvage reirradiation of head and neck cancer.

T. Padhya, D. Boulware, A. Trotti, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The results of complete lymph node dissections in 88 melanoma patients with positive sentinel nodes: 365

D. Reintgen, J. Messina, E. Joseph, 1997 .

Phase II Evaluation of 96-Hour Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck (E3395): A Trial of the Eastern Cooperative Oncology Group

S. Nair, C. Langer, R. Cohen, 2004, Cancer investigation.

Phase II Trial of Karenitecin in PatientswithMalignantMelanoma : Clinical andTranslational Study

A. Daud, F. Hausheer, R. Deconti, 2005 .

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma

V. Sondak, P. Munster, J. Messina, 2011, British Journal of Cancer.

Phase II trial of sagopilone (ZK-EPO), a novel epothilone, in patients with metastatic melanoma

V. Sondak, A. Daud, J. Weber, 2008 .

Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: preliminary results of two pilot trials using paclitaxel and cisplatin.

F. Khuri, S. Spencer, B. Murphy, 1999, Seminars in radiation oncology.

Clinical Safety , CorrelativeMarkers , andClinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma

C. Horak, M. Schell, G. Gibney, 2015 .

Accuracy of the subrenal capsule xenograft assay in predicting the clinical growth and chemosensitivity of human squamous head and neck carcinomas

J. Bennett, S. Parnes, R. Deconti, 1989, Journal of surgical oncology.

Treatment of advanced neoplastic disease with 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037).

J. Bertino, R. Deconti, S. Hubbard, 1973, Cancer chemotherapy reports.

Combination sequential chemotherapy in advanced reticulum cell sarcoma

J. Bertino, R. Deconti, J. Marsh, 1972, Cancer.

Accurate Nodal Staging of Malignant Melanoma.

Messina, D. Reintgen, J. Messina, 1995, Cancer control : journal of the Moffitt Cancer Center.

Vincristine, Actinomycin-0, and Cyclophosphamide for Advanced Sarcoma

D. Schoenfeld, J. Wolter, J. Horton, 2006 .

340 POSTER Gene therapy with plasmid IL-12 delivered by electroporation in patients with malignant melanoma: results of first human Phase I trial

V. Sondak, J. Messina, A. Daud, 2006 .

Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents.

S. Kaplan, R. Deconti, P. Calabresi, 1972, Blood.

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

V. Sondak, P. Munster, D. Sullivan, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor.

V. Sondak, A. Daud, D. Gabrilovich, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of sagopilone (ZK-EPO), a novel synthetic epothilone, with significant activity in metastatic melanoma.

V. Sondak, A. Daud, J. Weber, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.